ArticleClinics (Sao Paulo, Brazil)2021

Association of tumor mutation burden and epidermal growth factor receptor inhibitor history with survival in patients with metastatic stage III/IV non-small-cell lung cancer: A retrospective study.

Yan Lan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.